May 5, 2021

RSIP Vision launches AI-based MRI and ultrasound tool

Leila Hawkins
2 min
RSIP Vision launches AI-based MRI and ultrasound tech
RSIP Vision's new tool for prostate MRI and ultrasound scans will enable precise navigation during surgery...

RSIP Vision, a leading medical imaging firm, has launched an advanced AI tool for prostate MRI and ultrasound scans. The tool’s fully automated, deep learning-based capabilities uses a registered MRI scan of the prostate to visualise information on top of an ultrasound image, giving surgeons highly accurate, real-time information. 

In prostate-focused procedures, lack of information makes the surgeon’s decision process a challenging task. Research has found that the outcomes of surgical treatment vary widely depending on where and by whom the patient was treated; additionally variation in outcomes can be due to levels of technical skill and the interpretation of the data collected in the operating room. 

Currently, ultrasound alone is commonly used, however certain regions cannot be viewed clearly using just this method. 

Merging MRI and ultrasound

RSIP Vision’s tool can be used in frequent clinical tasks, such as biopsy acquisition and robotic prostate surgeries. During these procedures, MRI information is typically not available due to the complicated nature of its acquisition in real-time. By scanning the patient prior to surgery, it’s possible to merge the MRI image to an ultrasound scan that is acquired during surgery. 

By doing so, the MRI image can be created in real-time, and the regions the surgeon needs to see can be displayed as it would if real-time MRI acquisition were possible. This gives a surgeon many options, such as improved navigation to a tumor during a biopsy.  

Ron Soferman, CEO of RSIP Vision, says that MRI-to-ultrasound technology is an extremely valuable tool for a surgeon to have. "By having RSIP Vision’s new prostate MRI fusion tool at their fingertips, surgeons can avoid damaging sensitive internal structures" he said. 

"Surgeons can also locate clinically relevant regions and reduce procedural risks to patients. Our new tool also cuts down on surgery time, hospitalisation time and overall procedural costs. Most importantly, it gives surgeons the ability to make quick and accurate clinics decisions mid-procedure, alleviating the need to call for higher-level expertise." 

Share article

Jun 24, 2021

Jvion launches AI-powered map to tackle mental health crisis

2 min
Jvion's new interactive map uses AI to predict areas most vulnerable to poor mental health

Clinical AI company Jvion has launched an interactive map  of the US that highlights areas that are most vulnerable to poor mental health. 

The Behavioral Health Vulnerability Map uses Jvion's AI CORE™ software to analyse public data on social determinants of health (SDOH)  and determine the vulnerability of every US Census block group. 

Vulnerability refers to the likelihood that residents will experience issues like self-harm, suicide attempts or overdoses. The map also identifies the most influential social determinants in each region, to show the social and environmental conditions that contribute to mental illness. 

As an example, the map shows that Harrison County in Mississippi has a 50% higher suicide rate than the rest of the state. It also shows a high percentage of individuals in the armed forces at a time when active duty suicides are at a six-year high, along with a high prevalence of coronary artery disease, arthritis, and COPD, all chronic illnesses that are linked to a higher suicide risk.  

The map also shows Harrison County has a high percentage of Vietnamese Americans, who studies suggest have high rates of depression and may be less likely to seek help from mental health professionals. 

The map was built using the same data and analytics that Jvion used to create the COVID Community Vulnerability Map, which was launched towards the start of the pandemic. 

With this new map, Jvion is aiming to tackle the growing mental health crisis in the US. “At a time when so many Americans are struggling with their mental health, we’re proud to offer a tool that can help direct treatment resources to the communities that need it most,” said Dr John Showalter, MD, Jvion’s chief product officer, who led the development of the map. 

“For too long, the healthcare industry has struggled to address social determinants of health, particularly in the context of behavioural health. Our hope is that by surfacing the social and environmental vulnerabilities of America’s communities, we can better coordinate our response to the underlying conditions that impact the health and wellbeing of people everywhere.” 

Share article